June 14, 2011 – Positron, a molecular imaging company specializing in the field of nuclear cardiology, is relocating its corporate headquarters, research and development and product manufacturing facilities to Noblesville, Ind. Positron also plans to develop a high-energy 70 MeV cyclotron project and radiopharmaceutical manufacturing facility, also to be located in Noblesville.
Positron is proposing to make a capital investment of approximately $55 million for this project in conjunction with significant economic development incentives from the city of Noblesville and the state of Indiana, as well as various other project financing opportunities.
This cyclotron, once completed, will be the highest energy commercial cyclotron for isotope production within the United States and will advance Positron’s objectives for the production of medical isotopes and radiopharmaceuticals used in cardiac positron emission tomography (PET) imaging, diagnostic and therapeutic medical radiopharmaceuticals.
Positron’s development plans are expected to create more than 80 jobs in Noblesville over the next three to five years, a majority of which would be highly-skilled, professional positions. In addition, the city is expected to realize further economic benefits through complementary businesses locating in Noblesville in order to be in close proximity to this unique facility. The company believes Noblesville to be the ideal choice for expansion plans based on its growing economy, strategic location and the city’s commitment to promoting a thriving healthcare and technology environment.
Positron, the city of Noblesville and the state of Indiana are working to finalize a definitive agreement regarding the proposed incentive package for this project.
For more information: www.positron.com
July 30, 2024 
